By Gregory P. Luib & Mike Cowie, Dechert
“Big data” has become one of the hottest subjects for antitrust enforcers around the globe. There is concern that large tech companies are amassing vast amounts of data and will use that data to entrench their dominant positions. With this emerging view, more data may be viewed as anticompetitive.
Yet, recent transactions such as CVS-Aetna (in which Dechert represented CVS) and AT&T-Time Warner show how the use of data can be procompetitive, reducing costs and benefitting consumers in the process. Under the right circumstances, big data can drive substantial merger efficiencies, a key showing in obtaining merger clearance.
What Is Big Data?
As a threshold matter, what is big data? There is no consensus definition, but big data is often described as having four key characteristics (the “four Vs”): Volume (i.e. size and scale), Velocity (i.e. rate at which it is generated), Variety (i.e. different types and forms), and Value.1 Big data may be comprised of information that is provided by consumers or generated from such consumer information. It may be used to identify consumer preferences or to predict consumer behavior.
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI